Aurinia Pharmaceuticals

biotech development and commercialization

🤖

AI Overview

With $113K in lobbying spend across 5 quarterly filings, Aurinia Pharmaceuticals is an active lobbying client. Their lobbying covers 1 issue area. Active from 2018 to 2019.

$113K
Total Spend
2
Years Active
1
Firms Hired
1
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$90K
2019$23K

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Aurinia Pharmaceuticals disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATE
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues

Lupus

FDA approval of breakthrough therapies

Lupus

FDA approval of breakthrough therapies

drug pricing

drug pricing and coverage

lupus nephritis

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.